SCHEMBL7674549

SCHEMBL7674549

Cc1ccc(S(=O)(=O)N2Cc3cc(C#N)ccc3NC[C@H]2Cc2ccccc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FNTA P49354 11/20 0.53
▸ FNTB P49356 11/20 0.53
▸ PSEN1 P49768 1/20 0.44
▸ PSEN2 P49810 1/20 0.44
▸ APH1B Q8WW43 1/20 0.44
▸ NCSTN Q92542 1/20 0.44
▸ APH1A Q96BI3 1/20 0.44
▸ PSENEN Q9NZ42 1/20 0.44
▸ HRAS P01112 1/20 0.43
▸ KRAS P01116 1/20 0.43
▸ PGGT1B P53609 1/20 0.43
▸ MMP8 P22894 2/20 0.37
▸ MMP3 P08254 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ PAX8 Q06710 1/20 0.37
▸ MMP1 P03956 1/20 0.36
▸ MMP2 P08253 1/20 0.36
▸ MMP7 P09237 1/20 0.36
▸ MMP9 P14780 1/20 0.36
▸ MMP12 P39900 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5787316 0.93 FNTA (0.59) FNTAFNTBPSEN1PSEN2APH1B
SCHEMBL5787326 0.93 FNTA (0.59) FNTAFNTBPSEN1PSEN2APH1B
SCHEMBL6615448 0.91 FNTA (0.53) FNTAFNTBPSEN1PSEN2APH1B
SCHEMBL6615441 0.91 FNTA (0.53) FNTAFNTBPSEN1PSEN2APH1B
SCHEMBL5791085 0.90 FNTA (0.59) FNTAFNTBPSEN1PSEN2APH1B
SCHEMBL5791079 0.90 FNTA (0.59) FNTAFNTBPSEN1PSEN2APH1B
SCHEMBL6639321 0.90 FNTA (0.51) FNTAFNTBPSEN1PSEN2APH1B
SCHEMBL6634461 0.88 FNTA (0.49) FNTAFNTBPSEN1PSEN2APH1B
SCHEMBL6614927 0.88 FNTA (0.49) FNTAFNTBPSEN1PSEN2APH1B
SCHEMBL5755209 0.87 FNTA (0.53) FNTAFNTBPSEN1PSEN2APH1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6458783-B1 INHIBITION OF FARNESYL TRANSFERASE, WHICH IS AN ENZYME INVOLVED IN RAS ONCOGENE EXPRESSION, IS EFFECTED BY COMPOUNDS OF THE FORMULAS OF BENODIAZEPINE DERIVATIVES BRISTOL-MYERS SQUIBB COMPANY 2002-10-01 — — US disclosed
WO-2001081322-A1 NON-IMIDAZOLE BENZODIAZEPINE INHIBITORS OF FARNESYL PROTEIN TRANSFERASE BRISTOL-MYERS SQUIBB COMPANY (US) 2001-11-01 — — WO disclosed
Send feedback